Borderline Ovarian Tumors

[1]  M. E. Kirk,et al.  Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants. , 2003, Gynecologic oncology.

[2]  J. Squifflet,et al.  Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. , 2003, Fertility and sterility.

[3]  D. Querleu,et al.  Laparoscopic restaging of borderline ovarian tumours: results of 30 cases initially presumed as stage IA borderline ovarian tumours , 2003, BJOG : an international journal of obstetrics and gynaecology.

[4]  R. Kurman,et al.  Diagnostic Criteria and Behavior of Ovarian Seromucinous (Endocervical-Type Mucinous and Mixed Cell-Type) Tumors: Atypical Proliferative (Borderline) Tumors, Intraepithelial, Microinvasive, and Invasive Carcinomas , 2002, The American journal of surgical pathology.

[5]  C. Olsen,et al.  Surgical Staging in Patients With Ovarian Tumors of Low Malignant Potential , 2002, Obstetrics and gynecology.

[6]  F. Montz,et al.  Recurrent micropapillary serous ovarian carcinoma , 2002, Cancer.

[7]  D. Atallah,et al.  Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary , 2002, BJOG : an international journal of obstetrics and gynaecology.

[8]  D. Bodurka,et al.  Response and Survival in Patients With Progressive or Recurrent Serous Ovarian Tumors of Low Malignant Potential , 2002, Obstetrics and gynecology.

[9]  A. Berchuck,et al.  Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. , 2001, Gynecologic oncology.

[10]  P. Dickman,et al.  Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. , 2001, Gynecologic oncology.

[11]  J. Gu,et al.  Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential. , 2001, Journal of the National Cancer Institute.

[12]  C. Mangioni,et al.  Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  A. Lissoni,et al.  Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors. , 2001, Gynecologic oncology.

[14]  R. Kurman,et al.  Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. , 1999, The American journal of surgical pathology.

[15]  R. Scully,et al.  Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. , 1999, The American journal of surgical pathology.

[16]  D. Gershenson,et al.  The current status of surgical staging of ovarian serous borderline tumors , 1999, Cancer.

[17]  D. Gershenson,et al.  Serous borderline tumors of the ovary with noninvasive peritoneal implants , 1998, Cancer.

[18]  B. Modan,et al.  Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors. , 1998, Journal of the National Cancer Institute.

[19]  L. Levy,et al.  Ovarian serous borderline tumors with invasive peritoneal implants , 1998, Cancer.

[20]  C. la Vecchia,et al.  Treatment for fertility and risk of ovarian tumors of borderline malignancy. , 1998, Gynecologic oncology.

[21]  R. Kurman,et al.  Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. , 1996, The American journal of surgical pathology.

[22]  M. Sherman,et al.  Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. , 1996, The American journal of surgical pathology.

[23]  R. Barakat,et al.  Laparotomy to Complete Staging of Presumed Early Ovarian Cancer , 1996, Obstetrics and gynecology.

[24]  E. Yordan,et al.  Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  K. Jablonski,et al.  Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. , 1995, Human pathology.

[26]  V. Abeler,et al.  Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors. , 1993, Gynecologic oncology.

[27]  R. Kurman,et al.  The behavior of serous tumors of low malignant potential: are they ever malignant? , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[28]  J. Woodruff,et al.  Long-term follow-up of serous ovarian tumors of low malignant potential. , 1992, Gynecologic oncology.

[29]  R. Knapp,et al.  Unifocal origin of advanced human epithelial ovarian cancers. , 1992, Cancer research.

[30]  J. Leake Tumors of low malignant potential , 1992, Current opinion in obstetrics & gynecology.

[31]  R. Scully,et al.  Ovarian serous borderline tumors with stromal microinvasion : a report of 21 cases , 1990 .

[32]  Scully Re,et al.  Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases. , 1988 .

[33]  N. Weiss,et al.  Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones. , 1988, Cancer research.

[34]  W. R. Hart,et al.  Intestinal adenocarcinomas metastatic to the ovaries. A clinicopathologic evaluation of 22 cases. , 1987, The American journal of surgical pathology.

[35]  Aimo Ojala Studies on Bilirubin in Amniotic Fluid: With Special Reference to Liver Function Tests , 1971, Acta obstetricia et gynecologica Scandinavica. Supplement.